After I graduated from Kyushu University Graduate School of Medical Sciences in 2004, I started junior residency at Kyushu Medical Center and Kyushu University hospital from 2004 to 2006. Next, I worked as a senior resident at Kyushu Cancer Center hospital in 2006. Then, I researched about cancer stem cells at Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science.
I got Diplomate, Subspeciality Board of Medical Oncology in 2012, and worked as a chief resident National Cancer Center Hospital, Tokyo. At National Cancer Center Hospital, I researched about esophageal cancer chemotherapy mainly.
Then, I joined and worked at the department of Gastrointestinal and Clinical Oncology Division of Kyushu Cancer Center Hospital from 2013 to 2015. From 2015 to 2017, I was a head of Oncology division of Miyazaki Prefectural Miyazaki Hospital, and a main and leading member of Kyushu Medical Oncology Group and Kyushu-Yamaguchi Total Oncology Group, respectively. Now in 2018, I work in Karatsu Higashi-matsuura Medical Association Center as a doctor of internal medicine.
Medical Oncology (Mainly Gastrointestinal Cancer), Cancer stem cell (Basic research), Palliative medicine, General Medicine, Gastroenterology, Clinical study, Multi-disciplinary coordination and multi-disciplinary study.
Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation. Rinsho Ketsueki. 2006 Oct;47(10):1372-6.
A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy. Cancer Chemother Pharmacol (2014) 74:1207-15, DOI 10.1007/s00280-014-2597-3.
Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital. J Palliat Care Med 2015, 5:3 http://dx.doi.org/10.4172/2165-7386.1000219.
Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 2016 Oct; 27(9): 891-8.
Analysis of a questionnaire survey regarding current conditions against exposure to anticancer drugs and reports of cancer chemotherapy at outpatient departments in Japan. Pharmacology & Pharmacy, 2017, 8, 140-152.
Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells. Exp Cell Res. 2012 Sep 10;318(15):1799-807.
Human STEAP3 maintains tumor growth under hypoferric condition. Exp Cell Res. 2011 Nov 1;317(18):2582-91.
Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases. Anticancer research 2014, 34: 215-220.
Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. Anticancer research 2014, 34: 2035-2040.
Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.
Anti-Cancer Drugs 2016, 27(5): 457-63.
Efficacy and Safety of TAS-102 in clinical practice of salvage chemotherapy for metastatic colorectal cancer. Anticancer Research 2016 Apr; 36(4): 1959-66.
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours. Cancer Chemother Pharmacol, 2016 Jul 15 DOI 10.1007/s00280-016-3106-7.
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G). Gastric Cancer. 2017 May 11 DOI: 10.1007/s10120-017-0725-6.
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemotherapy Pharmacology, 2017 Jun 26. DOI 10.1007/s00280-017-3371-0.
Irinotecan mnotherapy as third-line or later treatment in advanved gastric cancer. Gastric Cancer, 21(3), 464-472 DOI 10.1007/s10120-017-0759-9.
Early tumor shrinkage indicates a favorable response to bevacizumab-based first-line chemotherapy for metastatic colorectal cancer. Anticancer Drugs, 2017 Sep 12 DOI 10.1097/CAD.0000000000000562.
Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer. Anticancer Res. 2017 Nov;37(11):6459-6468.
Successful chemoradiotherapy for neuroendocrine tumor grade 3 arising from the mandibular gingiva: a case report and literature review. Open Journal of clinical & medical case report, Volume 2 (2016) Issue 5: 1089.
A complete response to second-line chemotherapy with sunitinib of a gastrointestinal stromal tumor: A case report. Molecular and Clinical Oncology 2017 Jul; 7(1): 93-97.
Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report. J Med Case Rep. 2012, 6:315.
Systemic chemotherapy for metastatic non-mucinous appendiceal adenocarcinoma: a case report and literature review. Int canc conf J. 2012 Oct DOI10.1007/s13691-012-0060-z.
Successful Chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary artery Case Rep Oncol 2014;7:484-490.
Successful multimodal therapy for undifferentiated carcinoma with neuroendocrine differentiation in the clival region. Int canc conf J. 2014 July DOI 10.1007/s13961-014-0179-1.
Anti-HER2 combination chemotherapy for advanced gastric cancer associated with the Peutz-Jeghers syndrome: a case report and literature review. Int canc conf J. 2013 Nov DOI 10.1007/s13961-013-0139-1.
Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis. Molecular and Clinical Oncology 5: 579-582, 2016.
Research Interest: Current Professional Activity: Fibrilación Auricular, Miocardiopatía Hipertrófica, Micrornas,Remodelado Cardíaco
Research Interest: Biological Skills. Plasmid Amplification And Purification, Transformation, Transfection, Transduction,Protein Isolation, Western Blot, Cell Viability And Apoptosis Assay, FluorescenceMicroscopy, Flow Cytometry, Real-Time PCR, Tissue Processing, Tissue Culture,Immunohistochemistry, XF Flux Analyzer And Mice Handling.Biophysical Skills. A Complete Understanding Of Atomic Force Microscopy To Study IntrinsicallyUnstructured Proteins Related To Neurodegenerative Disease (Parkinson’s AndAlzheimer’s Disease).Bioinformatics Skills. Software: Python, Autodock, NCBI Software Suits, Rasmol, Clustal-X And W, VMD,Phylip, Tree View,Pymol, Arguslab And Genscan Etc. Biological Databases: Genbank, EMBL, DDBJ, Pfam, PDB, Swiss Prot, Trembl Etc. Muser Friendly With Proteomics Server Expasy.Information Technology Skills
Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development
Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.
Research Interest: Haematology Including Body Fluids, Clinical Biochemistry, Blood Bank, Clinical Microbiology, Cyto- Histopathology
Research Interest: Role of GPCR signaling in cancer progression and metastasis.
Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.
Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.
Research Interest: Population Based Analysis of Cancer Database, Lung Carcinoma
Research Interest: A dedicated head and neck pathologist, Bell’s research interest focuses on sinonasal and salivary gland tumors. The aim of her research is to find and apply new strategies and technologies to better understand key molecular changes during the pathogenesis of head and neck cancers, with emphasis on salivary gland and sinonasal tumors.
Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry
Research Interest: Cancer Immunotherapies Therapeutic Cancer Vaccines, Genitourinary Malignancies
Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.
Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.
Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research
Research Interest: New Insights Into The Development And Progression Of Aortic Valvestenosis (Thenid-¬‐PAS Study) Progression And Outcome Of Secondary Mitral Regurgitation (POMAR Registry)Radiation-¬‐Induced Heart Disease (AVRI Study): Animal Study Normal Reference Ranges For Echocardiography: Rationale, Study Design And Methodology(NORRE Study)
Research Interest: My Research Interests Include Targeted Delivery, Sirna Silencing, Apoptosis, Cancer Treatment, Multi-Drug Resistance, And Pharmaceutics In General
Research Interest: Her Major Scientific Interests Include Cancer Biology And Treatment, With Particular Emphasis On Sphingolipid Signalling In Cancer.
Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies
Research Interest: Bladder Cancer, Prostate Cancer, Renal Cancer, Urolithiasis And Uro-Gynaecology.
Research Interest: Head And Neck Pathology Section At The Department Of Surgical Pathology
Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.
Rsearch Interest: Molecular Biology, Cell Biology, Cancer Research
Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells
Research Interest: WT1-Specific Cytotoxic T-Lymphocytes That Have The Potential To Attack Tumor Cells
Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study
Research Interest: Toxicology And Pharmaceutical Applications Of Decavanadate; Ii) Muscle Contraction And Regulation; Iii) Insulin Mimetic Compounds.
Research Interest: Histopathology, Anatomical pathology, Experimental oncology
Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories
Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer
Research Interest: Lung Cancer, Surgery, Neoadjuvant Therapy, Photodynamic Therapy, Targeted Therapy, Malignant Pleural Effusion, Endobronchial Therapy.
Research Interest: Theoretical Chemistry, Physical Chemistry, Mathematical Chemistry, Computational Chemistry, Molecular Modelling, Simulation, And Design, Computer-Aided Drug Design And Development, Molecular Graphics And Representation Of Molecular Properties.
Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan
Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms
Research Interest: Theory and Mechanisms of Carcinogenesis and Metastasis; Breast Cancer; Endocrinology
Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response
Research Interest: Glioma, Circadian Gene, Radiotherapeutic Sensitivity, Carcinogenesis
Research Interest: Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase
Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.
Research Interest: Oncology,including basic and clinical
Research Interest: Minimal Invasion, Endoscopically Assisted Selective Neck Dissection, Functional Reconstruction, Mitochondrial Fission, Cisplatin Sensitivity, Mirna, Lncrna
Research Interest: Autophagy and Apoptosis
Research Interest: Highly Interested in Modern, Advanced Radiotherapy Techniques such as IMRT IGRT, Adaptive Radiotherapy and How to Use Them to Improve the Treatment Outcome of Cancer Patients
Research Interest: Potential Therapeutic Applications of Arteether, a Semi-Synthetized Derivative of Artemisinin on a Murine Model of Breast Cancer. As a Result, I Have Got Some Experience Atan Area of Tumor Immunology/Immunotherapynamed "Chemoimmunotherapy". Chemoimmunotherapy is an Approach for the Treatment of Cancers in Whichthe Focus is to enhance the Efficacy of chemotherapeutic Agents by Concomitant Application of Compounds with Immunomodulatory Properties. Besides my Thesis Work, I Managed to Do a Course in Cellular Immunology with Professor Hassan, One of the Well-Knownimmunologists in Iran, so that i could also Work on Cellular Immunology Aspects of Tumors. Moreover, Considering the Reported Associations between Molecular Players such as CTLA-4, PDL-1 and also Different Micrornas in Tumor Progression, i am Currently Planning to further Study these Associations in order to improve the Efficacy of Tumor Immunotherapy
Research Interest: Carcinoma Lung, Breast and Cervix
Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley
Research Interest: Natural Product Chemistry, Toxicology, Spectroscopy, Essential Oils
Research Interest: Clinical Oncology
Research Interest: The Synthesis and Evaluation of New Molecules for Anticancer Activity; QSAR and Drug Design; HPLC and Chiral Separation
Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells
Leeds Beckett University, UK
Archives of Community Medicine and Public Health
Dr. Rath Research Institute
1260 Memorex Drive, Santa Clara, USA
Global Journal of Cancer Therapy
Ohio State University, USA
Open Journal of Bioinformatics and Biostatistics
Vingolo Enzo Maria
Sapienza University of Rome, Italy
Journal of Clinical Research and Ophthalmology
Arghya Narayan Banerjee
Yeungnam University, South Korea
International Journal of Nanomaterials, Nanotechnology and Nanomedicine
Southeastern University, China
Trends in Computer Science and Information Technology
California South University, USA
Open Journal of Analytical and Bioanalytical Chemistry
Catholic University of Rome, Italy
Open Journal of Orthopedics and Rheumatology
Marco Matteo Ciccone
University of Bari , Italy
Archives of Organ Transplantation
Metaxas Memorial Anticancer Hospital , Greece
Annals of Bone Marrow Research